China cardiology market is projected to grow significantly at a CAGR of around 6.4% during the forecast period. Coronary bypass procedures, ONCAB, OPCAB, and heart valve replacement devices are widely adopted in China that further provided significant growth in the cardiology market. It is the most populous country and there are massive numbers of heart patients creating a huge demand for cardiology surgeries and devices. The factors responsible for heart diseases such as hypertension, diabetes, excessive consumption of alcohol, cholesterol and smoking are also growing across the region. Cardiology products such as guidewires, catheters, radial closure devices, micro guidewires and stent delivery catheters are the widely adopted products across the country. Favourable government regulations and policies enable the country to explore the cardiology market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/china-cardiology-market
The market is segmented on the basis of device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/china-cardiology-market
The companies which are contributing to the growth of the China cardiology market include Abbott Laboratories, Biotronik Inc., Boston Scientific Corp., Edwards Life Sciences Corp., General Electric Co., Lepu Medical Technology Co., Ltd, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
Market Segmentation
China Cardiology Market by Device Type
- Angioplasty
- Cardiovascular stents
- Cardiovascular catheters
- Cardiac rhythm management
- Cardiovascular assistive devices
China Cardiology Market by Drug Type
- Antithrombotic drugs
- Antidyslipidemic drugs
- Antihypertensive drugs
- Anti-stroke drugs
China Cardiology Market by Mechanism
- Beta blockers
- Beta agonists
- Alpha blockers
- Alpha agonists
- Sodium channel blockers
- Calcium channel blockers
- Vasodilators
- Renin inhibitors
- Angiotensin receptor blockers
- Diuretics
- Thrombolytics
China Cardiology Market by Surgeries Type
- Coronary artery bypass grafting
- Transmyocardial laser revascularization
- Heart valve repair
- Arrhythmia treatment
- Aneurysm repair
- Heart transplant
Company Profiles
- Abbott Laboratories
- Biotronik Inc.
- Boston Scientific Corp.
- Edwards Life Sciences Corp.
- General Electric Co.
- Lepu Medical Technology Co., Ltd
- Medtronic PLC
- MicroPort Scientific Corp.
- Mindray Medical International Ltd.
- Terumo Corp.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
